Our research integrates classical microbiology, whole genome sequencing, metagenomics, emerging molecular detection approaches, and targeted phenotypic analyses
It is used for diabetes management and weight loss in overweight or obese individuals
"A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes (SUSTAIN)"
This data helps your PlexusDx provider optimize your dose or recommend tirzepatide or combination therapy to ensure you reach your weight loss goals despite any setbacks
NONCLINICAL TOXICOLOGY Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1, and 3 mg/kg/day (2-, 8-, and 22fold the maximum recommended human dose [MRHD] of 2.4 mg/week, based on AUC) were administered to the males, and 0.1, 0.3, and 1 mg/kg/day (0.6-, 2-, and 5-fold MRHD) were administered to the females